Skip to main content

Compass Therapeutics, Inc.

CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001738021

In the last 90 days, Compass Therapeutics, Inc. insiders filed 3 open-market purchases and 0 sales; 171 institutions reported holding it in 13F filings for Q3 2026, worth $167.0M in total; no superinvestor holds it.

Holders of 5% or more of CMPX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Compass Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CMPX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tang Capital Management LLC13G/A9.99%17.2M shares0.00 ppfrom 9.99%Jan 16, 20255 filingsNov 14, 2025SEC
OrbiMed Advisors LLC13D/A8.90%15.2M shares−2.10 ppfrom 11.00%Jul 14, 20216 filingsAug 15, 2025SEC
Suvretta Capital Management, LLC13G/A8.20%14.1M shares+3.00 ppfrom 5.20%Aug 13, 20252 filingsAug 21, 2025SEC
BlackRock, Inc.13G5.20%9.27M shares+0.60 ppfrom 4.60%Feb 4, 20253 filingsJan 21, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

45 Schedule 13D and 13G filings on Compass Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CMPX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 10, 20266:55 AM ETState Street Corp13G4.30%7.74M shares−1.20 ppfrom 5.50%Below 5%Sep 30, 2026SEC
Aug 14, 20263:59 PM ETVivo Opportunity Fund Holdings, L.P.and 3 others13G/A4.00%7.21M shares−1.10 ppfrom 5.10%Below 5%Jun 30, 2026SEC
Aug 7, 20269:13 AM ETState Street Corp13G5.50%9.95M sharesNewJun 30, 2026SEC
May 15, 20264:06 PM ETBiotechnology Value Fund L Pand 9 others13G/A4.30%7.76M shares−0.80 ppfrom 5.10%Below 5%Mar 31, 2026SEC
Feb 13, 20264:30 PM ETBlackstone Holdings II L.P.and 7 others13G/A3.40%6.13M shares–Below 5%Dec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G5.20%9.27M shares+0.60 ppfrom 4.60%Dec 31, 2025SEC
Nov 14, 20256:35 PM ETVivo Opportunity Fund Holdings, L.P.and 3 others13G5.10%9.00M sharesNewSep 30, 2025SEC
Nov 14, 20254:17 PM ETTang Capital Management LLCand 5 others13G/A9.99%17.2M shares0.00 ppfrom 9.99%Sep 30, 2025SEC
Nov 14, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A9.99%17.2M shares+0.19 ppfrom 9.80%Sep 30, 2025SEC
Oct 29, 20255:24 PM ETBiotechnology Value Fund L Pand 9 others13G5.10%8.75M sharesNewOct 22, 2025SEC
Aug 21, 20259:07 AM ETSuvretta Capital Management, LLCand 2 others13G/A8.20%14.1M shares+3.00 ppfrom 5.20%Aug 13, 2025SEC
Aug 18, 20256:35 PM ETCommander Aggregator, LPand 3 others13D/A4.50%7.79M shares–Below 5%Aug 14, 2025SEC
Aug 15, 20255:28 PM ETOrbiMed Advisors LLCand 1 other13D/A8.90%15.2M shares−2.10 ppfrom 11.00%Aug 13, 2025SEC
Aug 14, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A9.80%13.5M shares+1.80 ppfrom 8.00%Jun 30, 2025SEC
Aug 14, 202510:49 AM ETRTW Investments, LPand 1 other13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Jun 30, 2025SEC
Aug 14, 20258:05 AM ETRTW Investments, LPand 1 other13G/A9.90%9.47M shares–Jun 30, 2025SEC
Aug 13, 20258:21 PM ETSuvretta Capital Management, LLCand 2 others13G5.20%7.15M sharesNewJun 30, 2025SEC
Aug 12, 20254:29 PM ETMPM Oncology Impact Management LP13G/A4.10%5.62M shares−2.10 ppfrom 6.20%Below 5%Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A4.60%6.40M shares−0.40 ppfrom 5.00%Below 5%Jun 30, 2025SEC
May 15, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A8.00%11.1M shares+2.60 ppfrom 5.40%Mar 31, 2025SEC
Apr 11, 20257:21 PM ETOrbiMed Advisors LLCand 3 others13D/A11.00%15.2M shares–Apr 9, 2024SEC
Feb 14, 20254:11 PM ETMPM Oncology Impact Management LP13G6.20%8.57M sharesNewDec 31, 2024SEC
Feb 12, 20259:39 AM ETAdage Capital Partners GP, L.L.C.and 3 others13G/A4.36%5.99M shares–Below 5%Dec 31, 2024SEC
Feb 4, 20253:45 PM ETBlackRock, Inc.13G5.00%6.89M sharesNewDec 31, 2024SEC
Jan 16, 20255:17 PM ETTang Capital Management LLCand 5 others13G5.40%7.40M sharesNewJan 8, 2025SEC
Nov 14, 2024Janus Henderson Group PLC13G/AOld format–––SEC
Aug 2, 2024Blackstone Holdings II L.P.13GOld format–New–SEC
Mar 22, 2024OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 7, 2024Adage Capital Partners GP, L.L.C.13G/AOld format–––SEC
Feb 1, 2024Janus Henderson Group PLC13GOld format–New–SEC
Nov 27, 2023Adage Capital Partners GP, L.L.C.13GOld format–New–SEC
Feb 14, 2023Rock Springs Capital Management LP13G/AOld format–––SEC
Feb 13, 2023Foresite Capital Fund V, L.P.13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Nov 14, 2022Commander Aggregator, LP13DOld format–New–SEC
Nov 10, 2022OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 15, 2022Rock Springs Capital Management LP13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Dec 30, 2021Rock Springs Capital Management LP13GOld format–New–SEC
Dec 17, 2021Anderson Errik13G/AOld format–––SEC
Nov 12, 2021Foresite Capital Fund V, L.P.13GOld format–New–SEC
Nov 9, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Jul 14, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC

Form 144: proposed insider sales

2 notices from officers, directors and other affiliates planning to sell Compass Therapeutics, Inc. shares, newest first.

Form 144 notices for CMPX
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Apr 9, 20256:58 PM ETOrbiMed Genesis Master Fund, L.P.Director · Shareholder3.57M$5.68MApr 9, 2025Jefferies LLCSEC
Apr 9, 20256:51 PM ETThe Biotech Growth Trust PLCDirector · Shareholder3.57M$5.68MApr 9, 2025Jefferies LLCSEC